Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 7:53 pm Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 2,709,292 3.000% | -1,723,310 (-38.88%) | View |
2024-11-14 6:08 pm Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | Avidity Partners Management LP | 0 0.000% | -6,360,212 (Position Closed) | View |
2024-11-14 4:03 pm Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | PFM Health Sciences LP | 4,306,671 4.800% | -2,174,093 (-33.55%) | View |
2024-11-14 11:58 am Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | BANK OF AMERICA CORP BAC | 5,048,513 5.600% | 5,048,513 (New Position) | View |
2024-11-12 1:25 pm Unchanged | 13G | CARIBOU BIOSCIENCES INC CRBU | VANGUARD GROUP INC | 4,618,268 5.110% | 0 (Unchanged) | View |
2024-11-04 11:21 am Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | VANGUARD GROUP INC | 4,618,268 5.110% | 4,618,268 (New Position) | View |
2024-10-17 12:12 pm Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | STATE STREET CORP STT | 1,618,243 1.800% | -3,501,423 (-68.39%) | View |
2024-02-23 4:15 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 4,432,602 5.000% | 435,057 (+10.88%) | View |
2024-02-14 4:06 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFM Health Sciences LP | 6,480,764 7.300% | 2,020,981 (+45.32%) | View |
2024-02-14 06:30 am Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 3,997,545 4.500% | -87,999 (-2.15%) | View |
2024-01-25 4:59 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | BlackRock Inc. BLK | 7,068,468 8.000% | 2,346,385 (+49.69%) | View |
2024-01-25 07:20 am Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | STATE STREET CORP STT | 5,119,666 5.790% | 1,920,773 (+60.04%) | View |
2024-01-08 4:18 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Avidity Partners Management LP | 6,360,212 7.200% | 6,360,212 (New Position) | View |
2023-07-20 4:15 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 4,085,544 5.100% | 4,085,544 (New Position) | View |
2023-07-10 09:10 am Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFIZER INC PFE | 4,690,431 7.100% | 4,690,431 (New Position) | View |
2023-02-14 4:06 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFM Health Sciences LP | 4,459,783 7.300% | 367,474 (+8.98%) | View |
2023-02-09 08:14 am Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | FMR LLC | 1,443,046 2.365% | -1,880,238 (-56.58%) | View |
2023-02-03 2:18 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | STATE STREET CORP STT | 3,198,893 5.240% | 3,198,893 (New Position) | View |
2023-02-03 12:10 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | BlackRock Inc. BLK | 4,722,083 7.700% | 4,722,083 (New Position) | View |
2022-06-01 5:23 pm Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | DUPONT E I DE NEMOURS & CO DD | 2,058,000 3.390% | -1,093,311 (-34.69%) | View |